Work

A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation

Year: 2012

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2012.12.005

Authors: Wallace Akerley, Kenneth Boucher, Nathan Rich, Lyle Egbert, Graydon Harker, Julie Bylund, Terry Van Duren, Chakravarthy Reddy

Institutions: University of Utah, Huntsman Cancer Institute, Intermountain Healthcare, Utah Cancer Specialists

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Intermountain Healthcare

OpenAlex ID: W2094661168

FWCI: 3.489

Cites: 25

Cited by: 24

Related to: 10